Assisted fundraising

Log in  |  Sign up

  • Home
  • Guides
  • Assets
  • Investors
    • VC funds
    • Tailored lists
    • Favorites
  • Academy
  • Privacy policy
    • Terms of Use
    • Privacy Policy
  • Help center
  • Return to waveup.com

Fund profile

Radius Ventures

Radius Ventures

New York, USA

Leading

About

Radius Ventures was a New York-based venture capital firm active from 1997 to 2024, focused exclusively on growth-equity and expansion-stage health and life sciences companies. Co-founded by Managing Partner Jordan S. Davis and Daniel C. Lubin, the firm took a domain-driven investment approach combined with a hands-on value-add model — pairing intellectual capital and strategic guidance with deep industry relationships to back companies transforming patient care, advancing medical innovation, and improving health outcomes. Over nearly three decades, Radius completed more than 40 portfolio investments and led rounds across medical devices, diagnostics, biopharmaceuticals, life science tools, healthcare services, and healthcare information technology. The firm realized 33 or more exits, including 3 IPOs and 21 acquisitions. Marquee outcomes include Conor Medsystems (IPO 2004, subsequently acquired by Johnson and Johnson in 2007 for $1.4 billion at $33.50 per share), Tactile Medical (IPO July 2016, ranked first in share-price performance among commercial-stage medtech IPOs for over two years), Tabula Rasa Healthcare (IPO September 2016, ranked first among commercial-stage healthcare IT and services IPOs for over two years), and BioStorage Technologies, acquired by Brooks Automation. The flagship Radius Venture Partners III, LP achieved top-quartile performance per the Cambridge Associates Q3 2024 Venture Capital Index. Radius formally wound down in 2024 after the final portfolio exit, EndoGastric Solutions, in July of that year. Jordan Davis now leads JSD Capital LLC advising successor vehicles, while Daniel Lubin serves as Chairman of Upsher Management Company. The firm's nearly three-decade track record stands as one of the most consistent records in dedicated health and life-sciences growth equity.

Details

Average check

$3M-$10M
$10M-$50M

Round

Series B
Series C+

Previous Investments

BiotechHealthtech & WellnessPharmaSaaS

Geo focus

USA

Highlights

40

Investments

Healthtech & Wellness

Biotech

Pharma

SaaS

Showing 0 lists

Filter by

Sort by

Contacts

Website

radiusventures.com

Social

Lists that include this fund